Tokyo, June 12 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061878) titled 'An Exploratory Study Evaluating the Clinical Significance of a Novel ALDH1 Activity-Detecting Probe Using Specimens from Patients with Pancreatic Cancer' on June 11.
Study Type:
Observational
Primary Sponsor:
Institute - Kanazawa University
Condition:
Condition - Pancreatic Cancer
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - In this study, residual specimens obtained from EUS-FNA performed for diagnostic purposes will be used to detect and quantify ALDH1-positive cells using a novel probe for ALDH1 activity. We will exploratorily evaluate (1) the technical feasibility of this approach, (2) its concordance with established pathological indicators, and (3) its association with clinical outcomes and treatment response.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 20
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - 1. Patients with suspected pancreatic cancer based on imaging examinations and undergoing EUS-FNA.
2. Patients who provide written informed consent for participation in this study.
3. Patients aged 20 years or older at the time of informed consent.
Key exclusion criteria - atients who are deemed unsuitable for participation in this study at the discretion of the investigator.
Target Size - 50
Recruitment Status:
Recruitment status - Open public recruiting
Date of protocol fixation - 2026 Year 04 Month 15 Day
Date of IRB - 2026 Year 04 Month 15 Day
Anticipated trial start date - 2026 Year 04 Month 15 Day
Last follow-up date - 2029 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070805
Disclaimer: Curated by HT Syndication.
